Back
Protalix BioTherapeutics Stock Price Chart
Sponsored
PLX
Sponsored
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report
Sell
40
PLX
Protalix BioTherapeutics
Last Price:
1.25
Seasonality Move:
3.83%
7 Day Trial
ALL ACCESS PASS
$
7
S&P Global: Private Equity Invests $36 Billion Into What?
Read More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight buying pressure.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.27 | Sell |
20-day SMA: | 1.4 | Sell |
50-day SMA: | 1.45 | Sell |
200-day SMA: | 1.66 | Sell |
8-day EMA: | 1.28 | Sell |
20-day EMA: | 1.36 | Sell |
50-day EMA: | 1.45 | Sell |
200-day EMA: | 1.61 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 37.31 | Sell |
Chaikin Money Flow: | 32249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.3 - 1.54) | Sell |
Bollinger Bands (100): | (1.38 - 1.68) | Sell |
Protalix BioTherapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.25 while PLX 8-day simple moving average is 1.27, which is a Sell signal.
- The stock price of PLX is 1.25 while Protalix BioTherapeutics 20-day SMA is 1.40, which makes it a Sell.
- Protalix BioTherapeutics 50-day simple moving average is 1.45 while PLX share price is 1.25, making it a Sell technically.
- PLX stock price is 1.25 and Protalix BioTherapeutics 200-day simple moving average is 1.66, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
40
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Sell
The current Protalix BioTherapeutics [PLX] share price is $1.25. The Score for PLX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
91.32M
Price in USD:
1.25
Share Volume:
378.2K
Protalix BioTherapeutics 52-Week Range
52-Week High:
3.55
52-Week Low:
1.21
Sell
40
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.25 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.25 while PLX 8-day exponential moving average is 1.28, which is a Sell signal.
- The stock price of PLX is 1.25 while Protalix BioTherapeutics 20-day EMA is 1.36, which makes it a Sell.
- Protalix BioTherapeutics 50-day exponential moving average is 1.45 while PLX share price is 1.25, making it a Sell technically.
- PLX stock price is 1.25 and Protalix BioTherapeutics 200-day simple moving average is 1.61, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Protalix BioTherapeutics is a Sell
- Protalix BioTherapeutics Relative Strength Index (RSI) is 37.31, which suggest Protalix BioTherapeutics is oversold
- The Bollinger Bands (25) for Protalix BioTherapeutics is (1.3 - 1.54), which suggest Protalix BioTherapeutics is a Sell
- The Bollinger Bands (100) for Protalix BioTherapeutics is (1.38 - 1.68), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.